Brian McNamara was appointed as CEO, GSK Consumer Healthcare in September 2016. The Consumer Healthcare business develops and markets products in Wellness, Oral health, Nutrition and Skin health with a portfolio of some of the world’s most trusted and best selling brands which include Sensodyne, Voltaren, Horlicks and Panadol. He is a member of the Corporate Executive Team. Brian joined GSK in March of 2015, as Head of Europe and Americas for GSK Consumer Healthcare, following the creation of a Joint Venture between GSK and Novartis.  Previously, as head of Novartis’s OTC division, Brian was a driving force behind the formation of the joint venture and the development of the 3 Year JV strategic and operational plan.  Brian joined Novartis in 2004 as Senior Vice President of the North America OTC business. Brian began his career at Procter and Gamble. Brian is a board member of the World Self-Medication Industry Association (WSMI)  and  was previously a Board Member and Chairman of the Economic Affairs Committee, Association for Europe Self-Medication Association (AESGP) and Board Member and Vice Chairman, Consumer Health Products Association (CHPA). Brian earned an undergraduate degree in Electrical Engineering from Union College in Schenectady, New York and an MBA in Finance from University of Cincinnati.

Pharmaceutics